Two former FDA leaders look at Commissioner Marty Makary’s early stumbles — and lay out a list of priorities to protect both ...

Biotech was starting to show signs of recovery after years of investor pullback—until new tariffs and economic uncertainty ...

Here’s what several large drugmakers said about tariffs when reporting earnings this morning: Merck made a small downward ...

Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

Shares of Viking Therapeutics have sold off sharply as the market awaits updates on its drug candidates. The company is ...

The expansion is a good signal for an industry that slowed down, both in Chicago and nationwide, as interest rates rose and ...

Stock market whiplash is dampening hopes ... s health agencies injected more uncertainty into the industry. And then came tariffs. “Biotech stocks have experienced heightened volatility in ...

Mid Cap Biotechnology Analyst Joseph and European Pharmaceuticals Analyst Gordon, along with Dr. Hogarth, Prof of Medicine in Pulmonary & Critical ...

With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

The Global Biotechnology Market is valued at USD 1.77 Trillion in 2024 and is projected to reach a value of USD 7.417 Trillion by 2035 at a CAGR (Compound Annual Growth Rate) of 13.95% over the ...

Designed to provide broad exposure to the Health Care ETFs category of the market, the First Trust NYSE Arca Biotechnology ETF (FBT) is a smart beta exchange traded fund launched on 06/19/2006. What ...

Directives from President Donald Trump's administration to freeze grant funding from the National Institutes of Health may ...